Study Stopped
Insufficient Recruitment
Spitex-SpiTal-Autonomie-Reha-Kraft
STARK
Efficacy of the STARK Comprehensive Autonomy Health Care Package in Functional Recovery After a Hip Fracture: A Randomized Controlled Trial
1 other identifier
interventional
5
1 country
1
Brief Summary
The primary purpose of this study is to test if the STARK comprehensive autonomy health care package improves lower extremity function over time at 6 weeks, 3, 6 and 12 months after hip or pelvis fracture compared to the standard of care.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started May 2017
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 4, 2017
CompletedStudy Start
First participant enrolled
May 5, 2017
CompletedFirst Posted
Study publicly available on registry
May 16, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 15, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
August 15, 2021
CompletedSeptember 1, 2021
August 1, 2021
4.3 years
May 4, 2017
August 26, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Lower extremity function
Lower extremity function will be measured by the Short Physical Performance Battery (SPPB)
12 months
Secondary Outcomes (17)
Gait speed
12 months
Gait speed
12 months
Grip strength
12 months
Repeated sit-to-stand
12 months
Rate of falls
12 months
- +12 more secondary outcomes
Other Outcomes (1)
Interaction of family carer with hip-fracture patient and health professionals
12 months
Study Arms (2)
STARK intervention
ACTIVE COMPARATORNew care concept for hip fracture patients
Standard Care
OTHERSwiss standard of care for hip fracture patients
Interventions
The STARK Intervention is a new care concept for hip fracture patients that enable hip fracture patient to return to their home directly after discharge from acute care. The STARK comprehensive autonomy health care package includes following services; * Multidisciplinary collaboration of geriatricians, nurses and Spitex (ambulant nursing service at home) starting already during acute care * Inspection of the environment at the patient's home * Care and autonomy support * Social life support * Secondary prevention strategies: * Home exercise program (3x/weeks) * Protein enriched food preparation (20g whey protein/day) * Support to take vitamin D supplementation (2000 IU/day) * Recommendation and support to eat calcium rich foods * Motivation to be physically active
Standard of Care involves inpatient rehabilitation or home-based or inpatient transitional nursing care
Eligibility Criteria
You may qualify if:
- Community-dwelling prior to the hip fracture event
- Living alone or with a partner/family member
- Living in the city of Zurich
- age 70+
- Acute hip or pelvis fracture after minimal trauma (resulting from a fall occurring from a standard height and without the involvement of others or a vehicle)
- Living at home without or with minimal (i.e. no more than 1x/day) support from the Spitex (ambulant nursing service) before the hip fracture
- Participant is mentally competent (judicious) based on the treating physicians' opinion at the screening visit.
- Inpatient rehabilitation or inpatient transitional care at a nursing home or ambulatory standard of care
- The participant understands the study procedures and voluntarily agree to participate in the study and comply with all its procedures by giving written informed consent
You may not qualify if:
- Patients who are expected to return home without help (i.e. no more care than Spitex 1x/day or physiotherapy 2x/week needed) directly after acute care are excluded.
- Conservative treatment of acute hip fracture or surgical treatment that does not allow full weight bearing after surgery
- Currently under cancer treatment or has active cancer (except for non-melanoma skin cancer)
- Major visual or hearing impairment (visual and/or hearing aids are allowed) or other serious illness that would preclude participation
- hour nursing care need as this cannot be offered within the STARK package
- Mobility impairment that precludes return to own apartment
- Planned nursing home admission after acute hospital stay
- Current participation in another clinical trial, or plans of such participation in the next 12 months (corresponding to the study duration)
- Inability to read and/or speak German to an extent necessary to understand instructions and participate in the study
- Unwilling to forego any additional vitamin D supplementation (bolus or regular intake).
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Zurichlead
- Spitex Zürich, Switzerlandcollaborator
- City of Zurich, Switzerlandcollaborator
- University Hospital, Zürichcollaborator
- University of Applied Sciences of Western Switzerlandcollaborator
- Ebnet Stiftung, Switzerlandcollaborator
Study Sites (1)
Dept. of Geriatrics and Aging Research, University of Zurich / Geriatric Clinic University Hospital Zurich
Zurich, Canton of Zurich, 8037, Switzerland
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Heike Bischoff-Ferrari, Prof.
Zentrum Alter und Mobilität
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 4, 2017
First Posted
May 16, 2017
Study Start
May 5, 2017
Primary Completion
August 15, 2021
Study Completion
August 15, 2021
Last Updated
September 1, 2021
Record last verified: 2021-08
Data Sharing
- IPD Sharing
- Will not share